F T Murray
Overview
Explore the profile of F T Murray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
471
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan M, Murray F, Karunaratne M, Perez A
Diabetes Obes Metab
. 2005 Dec;
8(1):31-8.
PMID: 16367880
Aim: Pioglitazone (PIO) has been shown to decrease insulin resistance in patients with type 2 diabetes, resulting in lowered blood glucose concentrations, lowered plasma insulin levels and lowered haemoglobin A1C...
2.
Diani A, Sawada G, Wyse B, Murray F, Khan M
Am J Physiol Endocrinol Metab
. 2003 Oct;
286(1):E116-22.
PMID: 14532171
Thiazolidinediones may slow the progression of type 2 diabetes by preserving pancreatic beta-cells. The effects of pioglitazone (PIO) on structure and function of beta-cells in KKA(y), C57BL/6J ob/ob, and C57BL/KsJ...
3.
Guay A, Spark R, Jacobson J, Murray F, Geisser M
Int J Impot Res
. 2002 Mar;
14(1):25-31.
PMID: 11896474
Yohimbine has had questionable effects in men with organic erectile dysfunction. We conducted this study to better define the population of men responsive to yohimbine, because tobacco was thought to...
4.
Saenger P, Pescovitz O, Bercu B, Murray F, Landy H, Brentzel J, et al.
Endocrine
. 2001 Sep;
15(1):51-6.
PMID: 11572326
Saizen (recombinant growth hormone [GH]), 0.2 mg/(kg x wk), was given in an open-label fashion for an average of 51 mo to 27 children with presumed idiopathic GH deficiency who...
5.
Bercu B, Murray F, FRASIER S, Rudlin C, ODea L, Brentzel J, et al.
Endocrine
. 2001 Sep;
15(1):43-9.
PMID: 11572324
In an open-label study, 69 children with organic or idiopathic growth hormone deficiency (GHD) were treated with recombinant human growth hormone (Saizen) for an average of 64.4 mo, with treatment...
6.
Silverstein J, Murray F, Malasanos T, Myers S, Johnson S, Frye K, et al.
Endocrine
. 2001 Sep;
15(1):15-7.
PMID: 11572320
Fifty children ages 4-10 yr with type 1 diabetes mellitus volunteered to participate in a study to evaluate and compare a new needle-free device developed for growth hormone delivery. Children...
7.
Ellis E, Grant M, Murray F, Wachowski M, Guberski D, Kubilis P, et al.
Free Radic Biol Med
. 1998 Jan;
24(1):111-20.
PMID: 9436620
This morphological study demonstrates a role for endothelial cells in generating reactive oxygen species in early stages of retinopathy in the BBZ/Wor rat, an obese, noninsulin dependent model of diabetes....
8.
Weinstock R, Murray F, Diani A, Sangani G, Wachowski M, Messina J
Pharmacology
. 1997 Apr;
54(4):169-78.
PMID: 9211562
Pioglitazone increases insulin sensitivity in vivo and in vitro. The effects of this agent on insulin-induced DNA synthesis and hepatic cell growth have not been determined. We examined the ability...
9.
Guay A, Heatley G, Murray F
Urology
. 1996 Dec;
48(6):912-6.
PMID: 8973677
Objectives: To validate the results of the home penile tumescence monitor versus the sleep laboratory studies of erectile function. Methods: We used both methods to study 18 episodes of rigidity...
10.
Vernet D, Cai L, Garban H, Babbitt M, Murray F, Rajfer J, et al.
Endocrinology
. 1995 Dec;
136(12):5709-17.
PMID: 7588327
Erectile dysfunction occurs frequently in human diabetes, and it is sometimes associated with hypogonadism. These conditions also develop in a model of insulin-dependent (type I) diabetes, the BB/WORdp (diabetic prone)...